ONA Therapeutics Strengthens Scientific Leadership Team
/PRNewswire/ -- ONA Therapeutics ("ONA"), which is focused on the discovery and development of therapeutic biologics targeting lipid metabolism in order to...
Stay updated with breaking news from Development At Genentech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- ONA Therapeutics ("ONA"), which is focused on the discovery and development of therapeutic biologics targeting lipid metabolism in order to...
Posted on 524 Shasqi, a clinical-stage biotechnology company developing precision activated oncology therapeutics with its proprietary Click Activated Protodrugs Against Cancer (CAPAC TM) platform, announced today the members of its strategic advisory board, which bring a range of expertise to the company including corporate strategy, clinical development, cellular biology, and cancer therapeutics. “Shasqi has made important progress during the last year with the initiation of our phase 1 clinical trial of SQ3370 and the advancem...